Original Source(s)
Related Content
Catheter stop orders may be losing ground
A 20-year national survey reveals substantial gains in infection surveillance but inconsistent use of strategies to limit unnecessary urinary catheterization.
October 19, 2026
-
4 min
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
FDA approves dostarlimab for advanced rectal cancer
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
-
3 min